Stock Detail
DAXOR CORPORATION
DXR @ Yahoo Finance | DXR Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $9.66 | $9.83 | $-0.24 | -2.42% | 0.40 | $9.90 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $9.83 | $9.54 | 7,899 | 40.77M | 1,905.5 | 4.19 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 9.97 | 9.82 | 9.68 | 9.53 | 9.39 |
Stock Profile
Daxor Corporation operates as a medical device manufacturing and biotechnology company in the United States. It is developing BVA-100, which measures human blood volume. This instrument is used in conjunction with a single use radiopharmaceutical diagnostic injection kit known as Volumex. BVA-100 has an accuracy of approximately 98% while also providing the predicted normal blood volume for that specific individual based on the height, weight, and sex of the patient. Daxor's patented Volumex utilizes Albumin I-131, a classic tracer used for blood volume measurement. The company, through its wholly owned subsidiary, Scientific Medical Systems, operates a frozen blood bank in New York that allows people to store their own blood utilizing cryobiology technology for approximately 10 years. In addition, Idant, a division of the Scientific Medical subsidiary, provides sperm banking services. The company also provides special screening for rare hereditary recessive genetic traits. Daxor was founded in 1970 and is based in New York City.